openPR Logo
Press release

Neuromodulation Market is expected to reach US$ 16,333.98 Mn With CAGR of 10.3% Till 2027 with Abbott; Boston Scientific Corporation; Medtronic; NeuroPace, Inc.; NeuroSigma, Inc.; NEVRO CORP; Synapse Biomedical Inc.; Soterix Medical Inc; Integer Holdings

06-07-2021 06:31 PM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
Neuromodulation Market

Neuromodulation Market

According to the latest study on “Neuromodulation Market Forecast to 2027 –COVID-19 Impact and Global Analysis – by Technology, Application, and End User,” the market was valued at US$ 7,613.45 million in 2019 and is projected to reach US$ 16,333.98 million by 2027; it is expected to grow at a CAGR of 10.3% during 2020–2027. The report highlights trends prevailing in the global neuromodulation market, and drivers and restraints pertaining to the market growth.

Download Sample PDF Neuromodulation Report Copy at: https://www.theinsightpartners.com/sample/TIPHE100001415/?openpr-10225

The growth of the neuromodulation market is driven by the factors such as increasing incidence of neurological disorders and growing developments in neuromodulation technology. Further, the rising demand of neurostimulation devices to treat chronic pain offer lucrative opportunities to the global neuromodulation market players. However, the high cost of neuromodulation devices hinders the market growth.

On the basis of technology, the neuromodulation market is bifurcated into external (non-invasive) neuromodulation and internal neuromodulation. In 2019, the internal neuromodulation segment accounted for a larger share of the market. The growth of the market for this segment is attributed to the rising number of product launches and increasing innovations in neuromodulation devices.

Abbott; Boston Scientific Corporation; Medtronic; NeuroPace, Inc.; NeuroSigma, Inc.; NEVRO CORP; Synapse Biomedical Inc.; Soterix Medical Inc; Integer Holdings Corporation; and Magstim are among the key players operating in the neuromodulation market. These companies focus on partnerships, product launches, and collaborations, among other business strategies, to sustain their market positions. For instance, in September 2020, Boston Scientific announced its WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) Systems for the European market. The portfolio comprises four MRI conditional and Bluetooth-enabled implantable pulse generators (IPGs). The products from this line feature rechargeable and non-rechargeable options, and an access to waveforms that help cover multiple pain areas.

Market Insights

Increasing Incidence of Neurological Disorders Drives Market Growth

Depression is the most common neurological disorder among all age groups. In the developing regions, most people suffer from depression owing to various socioeconomic factors such as financial stress and poverty. Other neurological disorders such as dystonia, Parkinson’s disease, and obsessive-compulsive disorder are usually observed in aging population. According to a study ‘Incidence and Prevalence of Major Neurologic Disorders,’ published in January 2018, ~36% of elderly have moderate or severe memory impairment in the US. Each year nearly 1.2 million adults are diagnosed with brain disorders, of which 51.3% is due to stroke and 21% due to Alzheimer’s disease. In addition, nearly 135 million people are diagnosed with Parkinson’s disease, traumatic brain injury, and epilepsy each year. Moreover, ~500,000 cases of brain tumor, multiple sclerosis, and amyotrophic lateral sclerosis are reported annually. Therefore, the growing prevalence of neurological disorders is consequently propelling the demand for neuromodulators as these help in relieving neurological symptoms. Furthermore, the rising demand for neurostimulation devices to treat chronic pain.

The report segments the global neuromodulation market as follows:

By Technology

External (Non-Invasive) Neuromodulation
Respiratory Electrical Stimulation
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Internal Neuromodulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Gastric Electrical Stimulation
Spinal Cord Stimulation
Vagus Nerve Stimulation

By Application

Chronic Pain Management
Failed Back Syndrome
Epilepsy
Tremor
Incontinence
Depression
Dystonia
Gastroparesis
Parkinson’s Disease
Obsessive-Compulsive Disorder
Migraine

By End User

Hospitals
Clinics
Home Healthcare

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
Italy
UK
Russia
Asia Pacific
China
India
South Korea
Japan
Australia
Middle East and Africa
South Africa
Saudi Arabia
UAE
South and Central America
Brazil
Argentina

Buy Complete Neuromodulation Report at: https://www.theinsightpartners.com/buy/TIPHE100001415/?openpr-10225

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuromodulation Market is expected to reach US$ 16,333.98 Mn With CAGR of 10.3% Till 2027 with Abbott; Boston Scientific Corporation; Medtronic; NeuroPace, Inc.; NeuroSigma, Inc.; NEVRO CORP; Synapse Biomedical Inc.; Soterix Medical Inc; Integer Holdings here

News-ID: 2299962 • Views:

More Releases from The Insight Partners

Current Transformer Market is expected to grow a CAGR of 6.1% from 2025 to 2031
Current Transformer Market is expected to grow a CAGR of 6.1% from 2025 to 2031
The Global Current Transformer Market 2031 that centers around Current Transformer Market examines the significant components with a top to bottom methodology and empowers the client to survey the drawn-out based interest additionally predicts explicit executions. This report gives subjective investigation, clarifying item scope and expounding Market experiences and standpoint. To Get Sample Copy of Report, Click Here - https://www.theinsightpartners.com/sample/TIPRE00027549/?utm_source=OpenPR&utm_medium=10607 (Our SAMPLE COPY of the report offers a quick
Healthy Eating Revolution Boosts Packaged Salad Dressings Market Growth Through 2031
Healthy Eating Revolution Boosts Packaged Salad Dressings Market Growth Through …
New York, US - October 06, 2025 -The Packaged Salad Dressings market is entering a period of dynamic innovation and expansion, with consumers seeking healthier, flavorful, and convenient dressing options. The market is expected to register steady growth from 2025 to 2031, fueled by evolving consumer preferences and distribution innovations. As more people globally adopt salads and healthy eating habits, demand for packaged dressings such as vinaigrette, ranch, balsamic, honey mustard,
High Flow Oxygen Therapy Devices Market Size, Growth Status and Better Investment Opportunities by 2031
High Flow Oxygen Therapy Devices Market Size, Growth Status and Better Investmen …
The Insight Partners analysts forecasts the latest report on "Global High Flow Oxygen Therapy Devices Market (Covid-19) Impact and Analysis by 2031", according to report; The High Flow Oxygen Therapy Devices Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the High Flow Oxygen Therapy Devices
Motor Protection Market Set for Robust Growth by 2031
Motor Protection Market Set for Robust Growth by 2031
The Insight Partners has published its latest research titled"Motor Protection Market Share, Size, Trends, and Forecast by 2031." The report projects consistent growth in the global motor protection market, fueled by increasing industrialization, advances in smart technologies, and tighter safety regulations. With growing infrastructure initiatives and the rise of intelligent systems, the market is poised for significant expansion in terms of size, market share, and innovation through 2031. Check valuable insights

All 5 Releases


More Releases for Neuromodulation

Neuromodulation Market worth $10.4 billion by 2027
Neuromodulation Market is projected to grow from USD 6.0 billion in 2022 to USD 10.4 billion by 2027, at a CAGR of 11.8% from 2022 to 2027, according to a new report by MarketsandMarkets™. The market is driven by government support for research on neurological disorder along with increasing prevalence of neurological disorders. Emerging economies are expected to provide lucrative growth opportunities for the market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=921&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral The internal neuromodulation
Neuromodulation Market worth $11.0 billion by 2028
Browse 195 market data Tables and 39 Figures spread through 210 Pages and in-depth TOC on "Neuromodulation Market by Type (Internal (Spinal Cord Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation), Application (Tremor, Epilepsy, Parkinson's Disease, Depression, Gastroparesis), and Region - Global Forecast to 2028 Neuromodulation Market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at
Neuromodulation Market: Charting Future Frontiers for 2030
The Neuromodulation market was valued USD 6.5 Billion in 2023 and projected to reach USD 15.3 Billion by 2030, growing at a CAGR of 13.0% during the forecast period of 2024-2030. The Neuromodulation Market report studies the competitive environment of the Neuromodulation Market based on company profiles and their efforts to increase product value and production. The Neuromodulation Market report discusses various factors driving or restraining the market, which will help
Incontinence Neuromodulation Market - Reclaiming Independence, Redefining Well-b …
Newark, New Castle, USA: The "Incontinence Neuromodulation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Incontinence Neuromodulation Market: https://www.growthplusreports.com/report/incontinence-neuromodulation-market/8696 This latest report researches the industry structure, sales, revenue,
Neuromodulation Devices Market Insights, Forecast to 2030
The report extensively examines the global Neuromodulation Devices market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Neuromodulation Devices . For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market
Neuromodulation Market Outlook 2022-2028
Neurological issues are characterized as problems that influence the mind as well as the nerves tracked down all through the human body and the spinal rope. Intense spinal line injury, Alzheimer's sickness, amyotrophic horizontal sclerosis (ALS), ataxia, chime paralysis, mind cancers, cerebral aneurysm, epilepsy, and seizures are a portion of the normal neurological issues. The biochemical, underlying, or electrical irregularities in the mind, spinal line, or different nerves bring about